BD unveils ultrasound tech for IV insertions
11 Apr 2023
The new, easy-to-use, advanced ultrasound device — called the Prevue II — features a special probe. BD designed the Prevue II to address an unmet need in IV access through real-time needle depth markers.
Franklin Lakes, New Jersey-based BD’s system includes the Cue needle tracking system. This offers high-quality ultrasound imaging of the needle trajectory. It also has compatibility with Cue needle tracking-enabled catheters. The company said simulated studies demonstrated that pairing a needle-tracking system with ultrasound guidance can help reduce the number of attempts and time to successful vessel access.
Citing the American Institute of Ultrasound in Medicine, BD said this may make vascular access procedures safer and easier.
BD designed the system with “clinician-friendly” features to expand the use of ultrasound in IV placement. Prevue II’s specialized probe helps reduce the learning curve. This ensures that clinicians can use the technology without changing their insertion technique or field of view.
“Difficult IV access remains far too common today, but the availability of the BD Prevue II System supports a future where every needlestick has a predefined pathway for successful placement,” said Eric Borin, worldwide president of medication delivery solutions. “BD is advancing the vision of a ‘One-Stick Hospital Stay,’ and first-stick success is the first requirement to fulfill that vision. First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence.”
BD aims to reduce unnecessary needlesticks by choosing the right vascular access device and placing it successfully the first time. about BD’s “One-Stick Hospital Stay” initiative here.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.